Lexatumumab
Jump to navigation
Jump to search
Lexatumumab | |
---|---|
Term | Lexatumumab |
Short definition | Lexatumumab (lek-suh-TOO-moo-mab) A substance being studied to treat some types of cancer. It attaches to a protein called TRAIL-R2 on the surface of some tumor cells, which can kill the tumor cells. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Lexatumumab - (pronounced) (lek-suh-TOO-moo-mab) A substance being studied to treat some types of cancer. It attaches to a protein called TRAIL-R2 on the surface of some tumor cells, which can kill the tumor cells. Lexatumumab is a type of monoclonal antibody. Also called Anti-TRAIL R2 mAb HGS-ETR2 and HGS-ETR2
External links
- Medical encyclopedia article on Lexatumumab
- Wikipedia's article - Lexatumumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski